Mono Pharmacare Limited IPO
NSE SMEListed On: Sep 7, 2023 at ₹ 29.0
₹ 224000 /8000 Shares
*Min Investment
28 Aug, 2023
Open Date30 Aug, 2023
Close Date04 Sep, 2023
Allotment Date07 Sep, 2023
Listing DateMono Pharmacare Limited IPO Issue Details
- Issue Price ₹26-28 per equity share
- Face Value ₹10 Per Equity Share
- Issue Price 5,500,000 shares(aggregating up to ₹14.84 Cr)
- Listing at NSE SME
- List Price 29.0
- Listing Date 2023-09-07
- Lead Manager Unistone Capital Pvt Ltd
- Registrar Bigshare Services Pvt Ltd
Mono Pharmacare Limited IPO Details
- Retail Portion 45%
Mono Pharmacare Limited IPO Documents
Mono Pharmacare Limited IPO Details
Mono Pharmacare Limited IPO is an SME IPO, priced at ₹26-28 per equity share. The equity shares have a face value of ₹10 Per Equity Share each and will be listed on the NSE SME platform.
The IPO bidding window is open from Aug 28, 2023 to Aug 30, 2023. The allotment is expected to be finalized on Sep 4, 2023, and the tentative listing date is Sep 7, 2023.
The registrar of the IPO is Bigshare Services Pvt Ltd, and
Mono Pharmacare Limited IPO Subscription Analysis And Details
| As on | QIB / NII | Retail | Total |
|---|---|---|---|
| Shares Offered / Reserved | 500,000 / 2,260,000 | 2,264,000 | 5,024,000 |
Day 1 28-08-23 06:00 PM | 0.00 / 0.19 x | 3.37 x | 1.60 x |
Day 2 29-08-23 06:00 PM | 0.04 / 0.75 x | 8.32 x | 4.09 x |
Day 3 30-08-23 06:00 PM | 10.89 / 8.00 x | 19.39 x | 13.42 x |
Mono Pharmacare Limited Valuations
Mono Pharmacare Limited Company Financials
| 31-Mar-22 | 31-Mar-21 | 31-Mar-20 | |
|---|---|---|---|
| Assets | 1,438.31 | 1,122.46 | 871.70 |
| Revenue | 3,710.27 | 2,837.83 | 1,168.90 |
| Profit After Tax | 35.09 | 9.51 | 1.99 |
About Mono Pharmacare Limited Company
Mono Pharmacare Limited is engaged in the business of marketing and distribution of pharmaceutical products.
The company offers Health Care products, Antibiotic medicines, Cough Cold Anti Allergic medicines, Antifungal medicines, Nutraceutical medicines, Analgesic & Antipyretic medicines, Antacid & Antiemetics medicines, Cardiac - Diabetic medicines, and cosmocare products.
Mono Pharmacare works with contract manufacturers to manufacture pharmaceutical products to sell them under their brand name DLS Export. The company acquired DLS Export in 2022, for an aggregate consideration of ₹ 609 lakhs, in order to grow its product portfolio in selected therapeutic areas.
As on February 28, 2023, the company has over 168 pharmaceutical companies as their distributors and stockists and also, and served over 3,036 customers/vendors who are a mix of retail pharmacy stores as well as wholesalers.
Mono Pharmacare Limited - Promoter(s)
Panilam Lakhatariya
Supal Lakhatariya
Pre Issue Share Holding : 81.02%
Post Issue Share Holding : %
Mono Pharmacare Limited IPO - Issue Objectives
To meet the working capital requirements
General corporate purposes
To meet the issue expenses.
Mono Pharmacare Limited IPO - FAQs
Ans. Mono Pharmacare Limited IPO is a SME IPO. The issue is priced at ₹26-28 per equity share. The minimum order quantity is 4000 Shares. The IPO opens on Aug 28, 2023, and closes on Aug 30, 2023. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE SME.
Ans. The Mono Pharmacare Limited IPO opens on Aug 28, 2023 and closes on Aug 30, 2023.
Ans. You can track the real-time subscription numbers using the links below:
Ans. The size of Mono Pharmacare Limited IPO is 5,500,000 shares(aggregating up to ₹14.84 Cr).
Ans. The Mono Pharmacare Limited IPO price band is set between ₹26-28 per equity share.
Ans. To apply for Mono Pharmacare Limited IPO, follow the steps given below:
- - Open the IPO Ji App or Website
- - Find Mono Pharmacare Limited IPO in the List of IPOs
- - Press Apply Button
- - Select Your Demat Account
- - Select Your Shares Quantity and Submit
- - Track Your IPO Status
Ans. The share allotment date of Mono Pharmacare Limited IPO is Sep 4, 2023.
Ans. The Mono Pharmacare Limited IPO will be listed on Sep 7, 2023.
Ans. Follow the steps to check the Mono Pharmacare Limited IPO allotment status online.
